title: Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice.
abstract: Severe pre-eclampsia and eclampsia are rare but serious complications of pregnancy that threaten the lives of mothers during childbirth. Evidence supports the use of magnesium sulfate (MgSO4) as the first line treatment option for severe pre-eclampsia and eclampsia. Eclampsia is the third major cause of maternal mortality in Pakistan. As in many other Low- and Middle-Income Countries (LMIC), it is suspected that MgSO4 is critically under-utilized in the country. There is however a lack of information on context-specific health system barriers that prevent optimal use of this life-saving medicine in Pakistan. Combining quantitative and qualitative methods, namely policy document review, key informant interviews, focus group discussions and direct observation at health facility, we explored context-specific health system barriers and enablers that affect access and use of MgSO4 for severe pre-eclampsia and eclampsia in Pakistan. Our study finds that while international recommendations on MgSO4 have been adequately translated in national policies in Pakistan, the gap remains in implementation of national policies into practice. Barriers to access to and effective use of MgSO4 occur at health facility level where the medicine was not available and health staff was reluctant to use it. Low price of the medicine and the small market related to its narrow indications acted as disincentives for effective marketing. Results of our survey were further discussed in a multi-stakeholder round-table meeting and an action plan for increasing access to this life-saving medicine was identified.
authors.affiliation: Alliance for Health Policy and System Research, World Health Organization, Geneva, Switzerland. Bigdelim@who.int
authors.forename: Maryam
authors.initials: M
authors.lastname: Bigdeli
authors.forename: Shamsa
authors.initials: S
authors.lastname: Zafar
authors.forename: Hafeez
authors.initials: H
authors.lastname: Assad
authors.forename: Adbul
authors.initials: A
authors.lastname: Ghaffar
mesh_terms: D001291:Attitude of Health Personnel; D004461:Eclampsia / Q000188:drug therapy* / Q000191:economics / Q000401:mortality*; D005260:Female; D006268:Health Facilities / Q000331:legislation & jurisprudence; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008278:Magnesium Sulfate / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D008428:Maternal Mortality; D010154:Pakistan; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000191:economics / Q000401:mortality*; D011247:Pregnancy
chemical_list: D008278:Magnesium Sulfate
references.citation: Lancet. 2002 Jun 1;359(9321):1877-90
references.pmid: 12057549
references.citation: Bull World Health Organ. 2007 Oct;85(10):763-7
references.pmid: 18038057
references.citation: PLoS Med. 2011 Aug;8(8):e1001079
references.pmid: 21886488
references.citation: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD000025
references.pmid: 21069663
references.citation: Health Policy Plan. 2012 Aug;27(5):365-73
references.pmid: 21821667
references.citation: BMC Health Serv Res. 2005 Nov 01;5:68
references.pmid: 16262902
references.citation: BMC Health Serv Res. 2010 Dec 16;10:340
references.pmid: 21162717
references.citation: Health Policy Plan. 2013 Oct;28(7):692-704
references.pmid: 23174879
references.citation: Bull World Health Organ. 2006 Aug;84(8):608-12
references.pmid: 16917647
references.citation: PLoS Med. 2011 Aug;8(8):e1001073
references.pmid: 21857809
references.citation: Int J Gynaecol Obstet. 2004 Jun;85 Suppl 1:S28-41
references.pmid: 15147852
references.citation: BMJ. 2005 Oct 1;331(7519):765-9
references.pmid: 16195297
references.citation: BJOG. 2007 Mar;114(3):300-9
references.pmid: 17166220